CTBP1 and ovarian carcinoma: In order to confirm that the DDUP protein, and not the CTBP1-DT lncRNA, confers CDDP resistance in ovarian cancer, a CRISPR/Cas9-KO system was used to establish DDUP KO (DDUP-/-)-PDOVCs#3 and -PDOVCs#4.